[lu-177]-pnt2002,abiraterone,enzalutamide
astellas,janssen,pfizer,point biopharma
['crpc', 'splash', '$pnt', 'point bio']
 $pnt point biopharma provides updated efficacy and safety data from the lead-in cohort of the phase 3 splash trial in mcrpc at esmo congress 2022 2022-09-10 07:05:00
??

Android app: https://t.co/WFvRyhQ4dv…

SEC Filings: @spacHero_SEC